Table 2.
List of the broad range of vaccine supply capabilities from 37 DCVMN member manufacturers, in 2018–19. First column shows the various levels of supply capacity from different manufacturers. Second column shows the number of respondents that reported the number of doses supplied in 2018–19. Third column denotes the number of manufacturers with WHO prequalified vaccines within each level of supply. Fourth column shows the number of vaccine doses collectively supplied in 2018–19 by manufacturers within the same level of capacity. Total number of vaccine doses collectively supplied in 2018–19, self-reported by 37 respondents ,was 3′456′079′910 doses. Number of doses include all vaccines, if monovalent or multivalent, and also all presentations, if single or multidose vials. Four (4) member manufacturers did not respond to the survey on number of doses supplied.
| Level of capacity in supply of vaccines in 2018/19 (in million doses) | Number of DCVMN members that reported vaccines supplied in 2018/19 | Number of DCVMN members with WHO PQed vaccines per capacity level | Number of doses collectively supplied by members per capacity level in 2018/19 |
|---|---|---|---|
| 0 | 4 | 0 | 0 |
| Up to 1 | 4 | 1 | 1.053.000 |
| 1–10 | 7 | 1 | 36.966.910 |
| 10–20 | 5 | 2 | 81.020.000 |
| 20–50 | 8 | 2 | 217.960.000 |
| 50–100 | 3 | 2 | 231.300.000 |
| 100–200 | 2 | 1 | 267.070.000 |
| More than 200 | 4 | 4 | 2.621.710.000 |
| Total | 37* | 13 | 3.456.079.910 |
4 member companies did not respond to the survey.